Post by jamshundred on Dec 8, 2012 22:26:31 GMT -5
Remember way back when on the DC2 board - the discussions of A2 testing that were being done without license permission? Remember the lawsuit that involved E. Gus Cothran and therefore Texas A&M, settled in what a seasoned attorney might consider record time several years ago?
And remember that the defendents were interconnected with several labs doing DNA testing?
Well, the lab that was operating offshore in what the lawsuit considered an attempt to circumvent patent rights is now out of business - part of the final settlement agreement.
Another interesting aside to all of this; Dr. Melba Ketchum has recently been in the news regarding her press releases that she has DNA tested and identified samples from Sasquatch, ( Bigfoot) and it is human.
Judy
OptiGen, LLC v. Texas A&M University System(Case Closed on 14 Nov 2012)
Case Number 5:09-cv-00457 Filed Date 17 Apr 2009
Judge(s) Glenn T. Suddaby Closed Date 14 Nov 2012
Court New York Northern District Court
Plantiff Details
Plaintiff(s) OptiGen, LLC (3)
Counter Claimant(s) Pinpoint DNA Technologies, Inc. (2) Richard B. Dobbins (2) International Genetics, Inc. (2) Genetic Fulfillment USA, LLC (2)
Attorney Jodyann Galvin
Law Firm Hodgson, Russ Law Firm
Defendant Details
Defendant(s) Texas A&M University System (2) International Genetics, Inc. (2) DNA Diagnostics, Inc. (1) Pinpoint DNA Technologies, Ketchum (1) Ernest Gus Cothran (2)
Counter Defendant(s) OptiGen, LLC (3)
Attorney David W. Kloss
Law Firm Kloss, Stenger Law FirmInc. (2) Richard B. Dobbins (2) Genetic Fulfillment USA, LLC (2) Melba S.
*******************************************************
Posted to the International Genetics, Inc. website:
In January and April 2009, OptiGen filed lawsuits arising out of the infringement of a number of patents to which OptiGen holds exclusive licenses. The consolidated actions charged the InGen defendants, among others, with infringement of patents related to the testing of PRCD (Progressive Rod-Cone Degeneration), CLAD (Canine Leukocyte Adhesion Deficiency), CSNB/prad (Congenital Stationary Night Blindness or Retinal Dystrophy), and FN (Autosomal Recessive Nephropathy). The testing of these genetic disorders is covered by the following patents to which OptiGen holds exclusive licenses: U.S. Patent Nos. 5,804,388; 7,312,037; 7,285,388; 6,210,897; 6,201,114; and 6,428,958. The InGen defendants offered to sell and sold DNA testing products that utilized the methods covered by OptiGen’s patents to customers located in the United States.
The InGen defendants have agreed to settle OptiGen’s claims. Under the settlement, the InGen defendants have, among other things, ceased any and all sales of testing related to these patents and have agreed not to resume any such testing in the future. The InGen defendants regret that their testing has caused confusion among the community of dog owners and breeders.
*******************************************************
And remember that the defendents were interconnected with several labs doing DNA testing?
Well, the lab that was operating offshore in what the lawsuit considered an attempt to circumvent patent rights is now out of business - part of the final settlement agreement.
Another interesting aside to all of this; Dr. Melba Ketchum has recently been in the news regarding her press releases that she has DNA tested and identified samples from Sasquatch, ( Bigfoot) and it is human.
Judy
OptiGen, LLC v. Texas A&M University System(Case Closed on 14 Nov 2012)
Case Number 5:09-cv-00457 Filed Date 17 Apr 2009
Judge(s) Glenn T. Suddaby Closed Date 14 Nov 2012
Court New York Northern District Court
Plantiff Details
Plaintiff(s) OptiGen, LLC (3)
Counter Claimant(s) Pinpoint DNA Technologies, Inc. (2) Richard B. Dobbins (2) International Genetics, Inc. (2) Genetic Fulfillment USA, LLC (2)
Attorney Jodyann Galvin
Law Firm Hodgson, Russ Law Firm
Defendant Details
Defendant(s) Texas A&M University System (2) International Genetics, Inc. (2) DNA Diagnostics, Inc. (1) Pinpoint DNA Technologies, Ketchum (1) Ernest Gus Cothran (2)
Counter Defendant(s) OptiGen, LLC (3)
Attorney David W. Kloss
Law Firm Kloss, Stenger Law FirmInc. (2) Richard B. Dobbins (2) Genetic Fulfillment USA, LLC (2) Melba S.
*******************************************************
Posted to the International Genetics, Inc. website:
In January and April 2009, OptiGen filed lawsuits arising out of the infringement of a number of patents to which OptiGen holds exclusive licenses. The consolidated actions charged the InGen defendants, among others, with infringement of patents related to the testing of PRCD (Progressive Rod-Cone Degeneration), CLAD (Canine Leukocyte Adhesion Deficiency), CSNB/prad (Congenital Stationary Night Blindness or Retinal Dystrophy), and FN (Autosomal Recessive Nephropathy). The testing of these genetic disorders is covered by the following patents to which OptiGen holds exclusive licenses: U.S. Patent Nos. 5,804,388; 7,312,037; 7,285,388; 6,210,897; 6,201,114; and 6,428,958. The InGen defendants offered to sell and sold DNA testing products that utilized the methods covered by OptiGen’s patents to customers located in the United States.
The InGen defendants have agreed to settle OptiGen’s claims. Under the settlement, the InGen defendants have, among other things, ceased any and all sales of testing related to these patents and have agreed not to resume any such testing in the future. The InGen defendants regret that their testing has caused confusion among the community of dog owners and breeders.
*******************************************************
